Back
Bicara Therapeutics Vs. Preformed Line Products Industry Stock Comparison
Sell
46
BCAX
Bicara Therapeutics
Last Price:
$12.45
Seasonality Move:
--
Buy
62
PLPC
Preformed Line Products
Last Price:
$144.96
Seasonality Move:
7.37%
Sell
46
Bicara Therapeutics (BCAX)
is a Sell
Is Bicara Therapeutics a Buy, Sell or Hold?
-
The current Bicara Therapeutics [BCAX] share price is $12.42. The Score for BCAX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
BCAX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Preformed Line Products (PLPC)
is a Buy
Is Preformed Line Products a Buy, Sell or Hold?
-
The current Preformed Line Products [PLPC] share price is $145.03. The Score for PLPC is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
PLPC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BCAX Stock Price Chart
What is Bicara Therapeutics's stock price today?
-
The Bicara Therapeutics share price today is $12.42Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCAX is experiencing selling pressure, which indicates risk of future bearish movement.
PLPC Stock Price Chart
What is Preformed Line Products's stock price today?
-
The Preformed Line Products share price today is $145.03Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLPC is experiencing slight buying pressure.
BCAX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.07 | Buy |
Relative Strength Index (14 RSI): | 42.78 | Sell |
Chaikin Money Flow: | -444852 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.31 - 14.39) | Sell |
Bollinger Bands (100): | (13 - 21.26) | Sell |
PLPC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.44 | Sell |
Relative Strength Index (14 RSI): | 66.47 | Buy |
Chaikin Money Flow: | 15747 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (125.53 - 143.37) | Buy |
Bollinger Bands (100): | (124.98 - 140.1) | Buy |
BCAX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.27 | Sell |
20-day SMA: | 13.51 | Sell |
50-day SMA: | 13.53 | Sell |
200-day SMA: | 0 | Buy |
8-day EMA: | 13.65 | Sell |
20-day EMA: | 13.58 | Sell |
50-day EMA: | 14.06 | Sell |
200-day EMA: | 11.13 | Buy |
PLPC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 125.58 | Buy |
20-day SMA: | 131.95 | Buy |
50-day SMA: | 133.54 | Buy |
200-day SMA: | 128.03 | Buy |
8-day EMA: | 129.06 | Buy |
20-day EMA: | 130.88 | Buy |
50-day EMA: | 132.75 | Buy |
200-day EMA: | 130.26 | Buy |
Bicara Therapeutics Earnings Growth & BCAX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.18 per share, and a decrease next year of $0.54 per share.
Preformed Line Products Earnings Growth & PLPC Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Bicara Therapeutics Technical Analysis
Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Preformed Line Products Technical Analysis
Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |